Tag Archives: oncology

zoom
-

A New Era of Cancer Care

Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the body’s immune system to detect and fight cancer. Researchers have coined immunotherapy as the “beginning to the end of cancer” and we continue to see the space flourish.

Continue reading

zoom
-

Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and OncoSec’s role in the fight to end cancer. We discuss the advantages of intratumoral therapy, the future of cancer care, and how OncoSec is positioned to solve a great unmet need in oncology. Check out the full interview for more!

zoom
diversity, workforce, immigration, millennials, donald trump, biotech, healthcare, technology, innovation
-

Why Diversity Is Essential

In President Donald Trump’s address to joint sessions of Congress, he announced the White House is planning to unveil a new executive order on immigration tailored to respond to recent court rulings. As you may know, federal judges put a hold on the President’s original executive order banning travelers from seven majority-Muslim countries to enter the US.

Continue reading

zoom
-

2014 Annual Letter To OncoSec Shareholders

A Letter to Our Shareholders

This is an important moment in cancer immunotherapy and we believe OncoSec is poised to make a real impact. During this pivotal time, it is important that we outline the core fundamentals of our company and our technology, so that you as shareholders will understand why all of us here at OncoSec are excited for the future.

Continue reading

zoom
-

Electroporation Key to Skin Cancer Treatment

One in five individuals is likely to suffer from skin cancer at some point in their lives, and the numbers are steadily increasing. Despite advances that have been made in sunscreen technology and growing public awareness of the need for sunscreen, data that were reported in Dermatology Times found that the average U.S. lifetime risk of invasive melanoma has increased from 1 in 600 in 1960 to 1 in 50 in 2008. As baby boomers grow older, there is an added risk that skin cancer and other sold tumor cancers will loom larger in their lives.

Continue reading

zoom
-

Introduction: Why Social-Digital now?

Every day, over 1,500 people in the US and an estimated 20,000 people around the world – just like you and me – will hear the news that they have been diagnosed with cancer. Thousands of them will be in the indication of melanoma or another lethal form of cancer. Those diagnosed with late stage cancer that has metastasized (spread to other parts of the body) will have to face the difficult fact that there is less than 50% chance that they will survive more than 5 years with this disease.

Continue reading